Updated Jul 16, 2026
Smith W Bradford has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Smith W Bradford appears in SEC filing context associated with Lyra Therapeutics, Inc. as of the 2026-05-15 filing date. The prompt does not include the specific title or role. Therefore, the biography is limited to noting that Bradford is an insider connected to Lyra Therapeutics according to the SEC filings, with further verification needed from the actual filing (e.g., 8-K, DEF 14A, or annual/reporting documents) or Lyra Therapeutics leadership pages to determine current position and responsibilities.
| Role | Insider |
|---|---|
| Notability | 52/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | LYRA | Lyra Therapeutics, Inc. | D — Derivative transaction | 640 | $0.00 |
Smith W Bradford appears in SEC filing context associated with Lyra Therapeutics, Inc. as of the 2026-05-15 filing date. The prompt does not include the specific title or role. Therefore, the biography is limited to noting that Bradford is an insider connected to Lyra Therapeutics according to the SEC filings, with further verification needed from the actual filing (e.g., 8-K, …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Smith W Bradford profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.